• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

TEMBDAI:LX

30.12 USD 0.12 0.40%

As of 00:59:30 ET on 11/21/2014.

Snapshot for Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund (TEMBDAI)

Year To Date: +29.21% 3-Month: +10.65% 3-Year: +42.45% 52-Week Range: 21.83 - 30.53
1-Month: +6.39% 1-Year: +39.77% 5-Year: +29.12% Beta vs NBI: 1.03

Mutual Fund Chart for TEMBDAI

No chart data available.
  • TEMBDAI:LX 30.12
  • 1M
  • 1Y
Interactive TEMBDAI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for TEMBDAI

Franklin Templeton Investment Funds - Franklin Biotechnology Discovery Fund is a SICAV incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equity securities of biotechnology companies and discovery research firms, located in the US and other countries (with market capitalisation of less than $2 billion).

Inception Date: 04-03-2000 Telephone: 352-46-66-67-1
Managers: EVAN MCCULLOCH / JEREL BANKS
Web Site: www.franklintempleton.lu

Fundamentals for TEMBDAI

NAV (on 2014-11-21) 30.12
Assets (M) (on 2014-10-31) 2,580.36
Fund Leveraged N
Minimum Investment 5,000.00
Minimum Subsequent Investment 1,000.00

Dividends for TEMBDAI

No dividends reported

Fees & Expenses for TEMBDAI

Front Load 5.75
Back Load 1.00
Current Mgmt Fee 1.00
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.81

Top Fund Holdings for TEMBDAI

Filing Date: 06/30/2014
Name Position Value % of Total
Gilead Sciences Inc 3,515,700 291,486,687 9.118%
Biogen Idec Inc 785,840 247,783,210 7.751%
Celgene Corp 2,767,200 237,647,136 7.434%
Amgen Inc 1,357,100 160,639,927 5.025%
Medivation Inc 1,994,000 153,697,520 4.808%
Regeneron Pharmaceuticals Inc 452,500 127,817,675 3.998%
Illumina Inc 592,400 105,767,096 3.309%
Incyte Corp 1,741,200 98,273,328 3.074%
Alexion Pharmaceuticals Inc 577,500 90,234,375 2.823%
Vertex Pharmaceuticals Inc 880,800 83,394,144 2.609%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil